Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial

Authors
Category Primary study
Year 1996
This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. LMWH is a safe, efficacious therapy for the secondary prevention of recurrent DVT relative to (the standard) warfarin therapy.
Epistemonikos ID: 296e41b7775ab57e96a8585d38699ca657666743
First added on: Apr 19, 2023